Israel Englander Galapagos Nv Transaction History

Millennium Management LLC

$192 Billion
Q4 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Galapagos Nv stock. As of the latest transaction made, Millennium Management LLC holds 42,275 shares of GLPG stock, worth $1.08 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

42,275

Previous 267,354 84.19%

Holding current value

$1.08 Million

Previous $7.7 Million 84.9%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$25.22 - $31.05 $5.68 Million - $6.99 Million	-225,079 Reduced 84.19%	42,275 $1.16 Million
Q3 2024 Nov 14, 2024	SELL	$24.2 - $30.67 $1.8 Million - $2.28 Million	-74,285 Reduced 21.74%	267,354 $7.7 Million
Q2 2024 Aug 14, 2024	BUY	$24.78 - $32.48 $423,465 - $555,050	17,089 Added 5.27%	341,639 $8.47 Million
Q1 2024 May 15, 2024	BUY	$32.2 - $42.44 $8.44 Million - $11.1 Million	261,994 Added 418.82%	324,550 $10.5 Million
Q4 2023 Feb 14, 2024	SELL	$31.87 - $40.71 $382,949 - $489,171	-12,016 Reduced 16.11%	62,556 $2.54 Million
Q2 2023 Aug 14, 2023	SELL	$37.4 - $44.52 $10.3 Million - $12.2 Million	-275,123 Reduced 78.68%	74,572 $3.03 Million
Q1 2023 May 15, 2023	SELL	$36.5 - $48.0 $206,590 - $271,680	-5,660 Reduced 1.59%	349,695 $13.5 Million
Q4 2022 Feb 14, 2023	BUY	$37.44 - $46.51 $7.27 Million - $9.03 Million	194,226 Added 120.54%	355,355 $15.8 Million
Q3 2022 Nov 14, 2022	BUY	$42.27 - $57.6 $5.75 Million - $7.84 Million	136,121 Added 544.31%	161,129 $6.87 Million
Q2 2022 Aug 15, 2022	SELL	$52.3 - $71.59 $15.2 Million - $20.8 Million	-290,123 Reduced 92.06%	25,008 $1.4 Million
Q1 2022 May 16, 2022	BUY	$51.32 - $68.5 $4.15 Million - $5.55 Million	80,951 Added 34.57%	315,131 $19.5 Million
Q4 2021 Feb 14, 2022	BUY	$47.03 - $57.12 $1.11 Million - $1.34 Million	23,535 Added 11.17%	234,180 $12.9 Million
Q3 2021 Nov 15, 2021	BUY	$52.17 - $70.2 $3.38 Million - $4.54 Million	64,696 Added 44.33%	210,645 $11.1 Million
Q2 2021 Aug 16, 2021	SELL	$68.86 - $83.34 $3.85 Million - $4.66 Million	-55,918 Reduced 27.7%	145,949 $10.1 Million
Q1 2021 May 17, 2021	BUY	$76.15 - $111.94 $8.63 Million - $12.7 Million	113,357 Added 128.07%	201,867 $15.6 Million
Q4 2020 Feb 16, 2021	BUY	$96.85 - $148.25 $7.23 Million - $11.1 Million	74,623 Added 537.36%	88,510 $8.76 Million
Q3 2020 Nov 16, 2020	BUY	$122.47 - $213.56 $398,884 - $695,564	3,257 Added 30.64%	13,887 $1.97 Million
Q2 2020 Aug 14, 2020	BUY	$185.52 - $231.25 $90,904 - $113,312	490 Added 4.83%	10,630 $2.1 Million
Q1 2020 May 14, 2020	SELL	$143.0 - $274.03 $670,241 - $1.28 Million	-4,687 Reduced 31.61%	10,140 $1.99 Million
Q4 2019 Feb 14, 2020	BUY	$146.12 - $215.82 $2.17 Million - $3.2 Million	14,827 New	14,827 $3.07 Million
Q3 2019 Nov 14, 2019	SELL	$130.44 - $187.64 $4.97 Million - $7.15 Million	-38,110 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$111.45 - $128.93 $651,648 - $753,853	5,847 Added 18.12%	38,110 $4.91 Million
Q1 2019 May 14, 2019	SELL	$89.61 - $117.78 $3.61 Million - $4.74 Million	-40,275 Reduced 55.52%	32,263 $3.8 Million
Q4 2018 Feb 14, 2019	BUY	$87.81 - $110.65 $809,344 - $1.02 Million	9,217 Added 14.56%	72,538 $6.66 Million
Q3 2018 Nov 14, 2018	BUY	$90.63 - $120.22 $2.7 Million - $3.59 Million	29,822 Added 89.02%	63,321 $7.12 Million
Q2 2018 Aug 14, 2018	SELL	$88.4 - $105.34 $95,206 - $113,451	-1,077 Reduced 3.11%	33,499 $3.09 Million
Q1 2018 May 15, 2018	SELL	$94.51 - $120.23 $1.02 Million - $1.3 Million	-10,828 Reduced 23.85%	34,576 $3.45 Million
Q4 2017 Feb 14, 2018	BUY	$84.48 - $104.02 $3.84 Million - $4.72 Million	45,404	45,404 $4.26 Million

Others Institutions Holding GLPG

# of Institutions

Shares Held

13.2M

Call Options Held

213K

Put Options Held

126K

View Full List

About GALAPAGOS NV

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.67B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

More about GLPG

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account